C.M. Bidwell & Associates’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$69.4K	Buy	+7,751	New	+$69.4K	0.04%	202
2021 Q4	–	Sell	-14,005	Closed	-$201K	–	554
2021 Q3	$201K	Hold	14,005	–	–	0.13%	147
2021 Q2	$221K	Buy	+14,005	New	+$221K	0.14%	132